CTEV (Claritev) Accounts Receivable : $89.8 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Claritev Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Claritev's accounts receivables for the quarter that ended in Dec. 2024 was $89.8 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Claritev's Days Sales Outstanding for the quarter that ended in Dec. 2024 was 35.28.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Claritev's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was $-307.80.

Claritev Accounts Receivable Historical Data

The historical data trend for Claritev's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Claritev Accounts Receivable Chart

Claritev Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Receivable

Get a 7-Day Free Trial

63.20

99.91

78.91

76.56

89.76

Claritev Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accounts Receivable	Get a 7-Day Free Trial															76.56	82.44	81.42	82.13	89.76

Claritev Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Claritev Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Claritev's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	89.758	/	232.145	*	91
=	35.28

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Claritev's accounts receivable are only considered to be worth 75% of book value:

Claritev's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(16.848	+	0.75 * 89.758	+	0.5 * 0	-	5066.805
-	0	-	0)	/	16.188
=	-307.80

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Claritev Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Claritev's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Claritev Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Claritev Corp (NYSE:CTEV) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

7900 Tysons One Place, Suite 400, McLean, VA, USA, 22102

Website

https://www.claritev.com

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Executives

Michael Kim	officer: See Remarks	POLARIS PARENT CORP, 115 FIFTH AVENUE, NEW YORK NY 10003
Anthony Jr Colaluca	director	MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
John Michael Prince	director	115 FIFTH AVE., NEW YORK NY 10003
Nutter Carol	officer: SVP, Chief People Officer	115 FIFTH AVE., NEW YORK NY 10003
Mark Tabak	director, officer: Chief Executive Officer	115 FIFTH AVENUE, NEW YORK NY 10003
Michael K. Attal	director	425 PARK AVENUE, 30TH FLOOR, NEW YORK NY 10022
James M Head	officer: EVP & Chief Financial Officer	3001 COLORADO BLVD, DENTON TX 76210
Julie D Klapstein	director	1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259
C Martin Harris	director
H&f Corporate Investors Viii, Ltd.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
Music Investments Gp, Llc	10 percent owner	C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Music Investments, L.p.	10 percent owner	C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Glenn R August	director	C/O OHA - 1114 AVENUE OF THE AMERICAS, 27TH FLOOR, NEW YORK NY 10036
Paul Galant	officer: President, New Markets	88 WEST PLUMERIA DRIVE, SAN JOSE CA 95134
Michael Stuart Klein	director, 10 percent owner, officer: Chief Executive Officer	C/O DAVIS POLK & WARDWELL, 450 LEXINGTON AVENUE, NEW YORK NY 10017